PubMed:7524825 / 930-1275
Annnotations
Glycan-Motif
{"project":"Glycan-Motif","denotations":[{"id":"T11","span":{"begin":263,"end":267},"obj":"https://glytoucan.org/Structures/Glycans/G00054MO"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos6-Glycan-Motif-Image
{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T11","span":{"begin":263,"end":267},"obj":"Glycan_Motif"}],"attributes":[{"id":"A11","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos6-Glycan-Motif-Structure
{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T11","span":{"begin":263,"end":267},"obj":"https://glytoucan.org/Structures/Glycans/G00054MO"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
Glycosmos6-MAT
{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":96,"end":100},"obj":"http://purl.obolibrary.org/obo/MAT_0000037"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":345},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":345},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":345},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T31","span":{"begin":24,"end":34},"obj":"FMAID:62860"},{"id":"_T32","span":{"begin":24,"end":34},"obj":"FMAID:167159"},{"id":"_T33","span":{"begin":24,"end":34},"obj":"FMAID:167158"},{"id":"_T34","span":{"begin":46,"end":57},"obj":"FMAID:242132"},{"id":"_T35","span":{"begin":46,"end":57},"obj":"FMAID:242133"},{"id":"_T36","span":{"begin":46,"end":57},"obj":"FMAID:264827"},{"id":"_T37","span":{"begin":46,"end":57},"obj":"FMAID:242138"},{"id":"_T38","span":{"begin":46,"end":57},"obj":"FMAID:264828"},{"id":"_T39","span":{"begin":46,"end":57},"obj":"FMAID:242139"},{"id":"_T40","span":{"begin":46,"end":57},"obj":"FMAID:264829"},{"id":"_T41","span":{"begin":46,"end":57},"obj":"FMAID:264826"},{"id":"_T42","span":{"begin":46,"end":57},"obj":"FMAID:201491"},{"id":"_T43","span":{"begin":46,"end":57},"obj":"FMAID:86578"},{"id":"_T44","span":{"begin":46,"end":57},"obj":"FMAID:264830"},{"id":"_T45","span":{"begin":46,"end":57},"obj":"FMAID:242137"},{"id":"_T46","span":{"begin":46,"end":57},"obj":"FMAID:242134"},{"id":"_T47","span":{"begin":46,"end":57},"obj":"FMAID:264825"},{"id":"_T48","span":{"begin":46,"end":57},"obj":"FMAID:201492"},{"id":"_T49","span":{"begin":46,"end":57},"obj":"FMAID:86579"},{"id":"_T50","span":{"begin":46,"end":57},"obj":"FMAID:242140"},{"id":"_T51","span":{"begin":46,"end":57},"obj":"FMAID:264824"},{"id":"_T52","span":{"begin":46,"end":57},"obj":"FMAID:264823"},{"id":"_T53","span":{"begin":46,"end":57},"obj":"FMAID:264831"},{"id":"_T54","span":{"begin":46,"end":57},"obj":"FMAID:264822"},{"id":"_T55","span":{"begin":46,"end":57},"obj":"FMAID:242142"},{"id":"_T56","span":{"begin":46,"end":57},"obj":"FMAID:242143"},{"id":"_T57","span":{"begin":46,"end":57},"obj":"FMAID:264821"},{"id":"_T58","span":{"begin":46,"end":57},"obj":"FMAID:197973"},{"id":"_T59","span":{"begin":46,"end":57},"obj":"FMAID:84051"},{"id":"_T60","span":{"begin":46,"end":57},"obj":"FMAID:264832"},{"id":"_T61","span":{"begin":46,"end":57},"obj":"FMAID:242135"},{"id":"_T62","span":{"begin":46,"end":57},"obj":"FMAID:242136"},{"id":"_T63","span":{"begin":46,"end":57},"obj":"FMAID:242141"},{"id":"_T64","span":{"begin":46,"end":64},"obj":"FMAID:201496"},{"id":"_T65","span":{"begin":46,"end":64},"obj":"FMAID:86583"},{"id":"_T66","span":{"begin":86,"end":100},"obj":"FMAID:70317"},{"id":"_T67","span":{"begin":86,"end":100},"obj":"FMAID:171155"},{"id":"_T68","span":{"begin":96,"end":100},"obj":"FMAID:217490"},{"id":"_T69","span":{"begin":96,"end":100},"obj":"FMAID:217063"},{"id":"_T70","span":{"begin":96,"end":100},"obj":"FMAID:50723"},{"id":"_T71","span":{"begin":96,"end":100},"obj":"FMAID:185470"},{"id":"_T72","span":{"begin":96,"end":100},"obj":"FMAID:171667"},{"id":"_T73","span":{"begin":101,"end":112},"obj":"FMAID:63916"},{"id":"_T74","span":{"begin":101,"end":112},"obj":"FMAID:162384"},{"id":"_T75","span":{"begin":101,"end":118},"obj":"FMAID:69075"},{"id":"_T76","span":{"begin":101,"end":118},"obj":"FMAID:164926"},{"id":"_T77","span":{"begin":101,"end":118},"obj":"FMAID:66772"},{"id":"_T78","span":{"begin":101,"end":118},"obj":"FMAID:169653"},{"id":"_T79","span":{"begin":113,"end":118},"obj":"FMAID:169002"},{"id":"_T80","span":{"begin":113,"end":118},"obj":"FMAID:68646"},{"id":"_T81","span":{"begin":174,"end":185},"obj":"FMAID:167158"},{"id":"_T82","span":{"begin":174,"end":185},"obj":"FMAID:62860"},{"id":"_T83","span":{"begin":174,"end":185},"obj":"FMAID:167159"},{"id":"_T84","span":{"begin":207,"end":213},"obj":"FMAID:165145"},{"id":"_T85","span":{"begin":268,"end":283},"obj":"FMAID:196731"},{"id":"_T86","span":{"begin":268,"end":283},"obj":"FMAID:82742"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
uniprot-human
{"project":"uniprot-human","denotations":[{"id":"T9","span":{"begin":63,"end":69},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T13","span":{"begin":59,"end":69},"obj":"http://www.uniprot.org/uniprot/P01584"},{"id":"T14","span":{"begin":59,"end":69},"obj":"http://www.uniprot.org/uniprot/P42701"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
uniprot-mouse
{"project":"uniprot-mouse","denotations":[{"id":"T9","span":{"begin":59,"end":69},"obj":"http://www.uniprot.org/uniprot/P10749"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlycoBiology-NCBITAXON
{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T8","span":{"begin":65,"end":69},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T9","span":{"begin":65,"end":69},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T10","span":{"begin":113,"end":118},"obj":"http://purl.bioontology.org/ontology/STY/T025"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T13","span":{"begin":59,"end":69},"obj":"http://purl.obolibrary.org/obo/GO_0032611"},{"id":"T14","span":{"begin":63,"end":79},"obj":"http://purl.obolibrary.org/obo/GO_0036364"},{"id":"T15","span":{"begin":63,"end":79},"obj":"http://purl.obolibrary.org/obo/GO_0046509"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GO-MF
{"project":"GO-MF","denotations":[{"id":"T31","span":{"begin":59,"end":64},"obj":"http://purl.obolibrary.org/obo/GO_0005149"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GO-CC
{"project":"GO-CC","denotations":[{"id":"T5","span":{"begin":113,"end":118},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"T1","span":{"begin":86,"end":100},"obj":"http://purl.obolibrary.org/obo/UBERON_0002066"},{"id":"T2","span":{"begin":86,"end":112},"obj":"http://purl.obolibrary.org/obo/UBERON_0007777"},{"id":"T3","span":{"begin":96,"end":100},"obj":"http://purl.obolibrary.org/obo/UBERON_0001638"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlycoBiology-MAT
{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":96,"end":100},"obj":"http://purl.obolibrary.org/obo/MAT_0000037"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlycoBiology-Motifs
{"project":"GlycoBiology-Motifs","denotations":[{"id":"T9","span":{"begin":263,"end":267},"obj":"http://rdf.glycoinfo.org/glycan/G00054MO"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":96,"end":100},"obj":"http://purl.obolibrary.org/obo/UBERON_0001638"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":86,"end":100},"obj":"http://purl.obolibrary.org/obo/UBERON_0002066"},{"id":"PD-UBERON-AE-B_T3","span":{"begin":86,"end":112},"obj":"http://purl.obolibrary.org/obo/UBERON_0007777"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
Anatomy-MAT
{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":96,"end":100},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000037"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos15-NCBITAXON
{"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T1","span":{"begin":80,"end":85},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos15-CL
{"project":"GlyCosmos15-CL","denotations":[{"id":"T2","span":{"begin":24,"end":34},"obj":"Cell"},{"id":"T3","span":{"begin":96,"end":118},"obj":"Cell"},{"id":"T4","span":{"begin":174,"end":185},"obj":"Cell"}],"attributes":[{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000775"},{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0002543"},{"id":"A4","pred":"cl_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL:0000775"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos15-UBERON
{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T2","span":{"begin":24,"end":34},"obj":"Body_part"},{"id":"T3","span":{"begin":86,"end":100},"obj":"Body_part"},{"id":"T4","span":{"begin":101,"end":118},"obj":"Body_part"},{"id":"T5","span":{"begin":174,"end":185},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL_0000775"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002066"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL_0000115"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CL_0000775"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos15-MAT
{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":96,"end":100},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000037"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":345},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":345},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":345},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T7","span":{"begin":0,"end":345},"obj":"Sentence"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
NCBITAXON
{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":80,"end":85},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T2","span":{"begin":24,"end":34},"obj":"Body_part"},{"id":"T3","span":{"begin":86,"end":100},"obj":"Body_part"},{"id":"T4","span":{"begin":101,"end":118},"obj":"Body_part"},{"id":"T5","span":{"begin":174,"end":185},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL_0000775"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002066"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL_0000115"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CL_0000775"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}
CL-cell
{"project":"CL-cell","denotations":[{"id":"T2","span":{"begin":24,"end":34},"obj":"Cell"},{"id":"T3","span":{"begin":96,"end":118},"obj":"Cell"},{"id":"T4","span":{"begin":174,"end":185},"obj":"Cell"}],"attributes":[{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000775"},{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0002543"},{"id":"A4","pred":"cl_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL:0000775"}],"text":"An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM."}